Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis

References

• Matkovic Z, Miravitlles M. Chronic bronchial infection in COPD Is there an infective phenotype? Respir Med. 2013;107:10–22.
   PubMed Web of Science ®Google Scholar
• de la Rosa Carrillo D, Lopez-Campos JL, Alcazar Navarrete B, et al. Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease. Arch Bronconeumol. 2020;56:651–664.
   PubMed Web of Science ®Google Scholar
• Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759–764.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J. 2004;23:685–691.
   PubMed Web of Science ®Google Scholar
• Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:991–998.
   PubMed Web of Science ®Google Scholar
• Beech AS, Lea S, Kolsum U, et al. Bacteria and sputum inflammatory cell counts; a COPD cohort analysis. Respir Res. 2020;21:289.
   PubMed Web of Science ®Google Scholar
• Fuschillo S, Martucci M, Donner CF, Balzano G. Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med. 2012;106:915–923.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Calle M, Molina J, et al. Spanish COPD Guidelines (GesEPOC) 2021: updated Pharmacological treatment of stable COPD. Arch Bronconeumol. 2022;58:69–81.
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed May 16, 2021.
   Google Scholar
• Martínez-García MÁ, Faner R, Oscullo G, et al. Risk factors and relation with mortality of a new acquisition and persistence of Pseudomonas aeruginosa in COPD Patients. COPD. 2021;18:333–340.
   PubMedGoogle Scholar
• Martinez-Garcia MA, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Resp J. 2014;43:1357–1367.
   PubMed Web of Science ®Google Scholar
• Amin R, Lam M, Dupuis A, Ratjen F. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis. Pediatr Pulmonol. 2011;46:554–558.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Maiz L, Olveira C, et al. Spanish Guidelines on the treatment of Bronchiectasis in Adults. Arch Bronconeumol. 2018;54:88–98.
   PubMed Web of Science ®Google Scholar
• Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.
   PubMed Web of Science ®Google Scholar
• Eklof J, Sorensen R, Ingebrigtsen TS, et al. Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Clin Microbiol Infect. 2020;26:227–234.
   PubMed Web of Science ®Google Scholar
• Almagro P, Salvado M, Garcia-Vidal C, et al. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration. 2012;84:36–43.
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Ochs-Balcom HM, Noyes K, et al. Impact of Pseudomonas aeruginosa isolation on mortality and outcomes in an outpatient chronic obstructive pulmonary disease cohort. Open Forum Infect Dis. 2020;7:ofz546.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Raste Y, Reid J, Alshafi K, Polkey MI, Hopkinson NS. Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Eur Respir J. 2014;44(3):794–797.
   PubMed Web of Science ®Google Scholar
• Rodrigo-Troyano A, Melo V, Marcos PJ, et al. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: a Prospective Multicentre Study. Respiration. 2018;96:417–424.
   PubMed Web of Science ®Google Scholar
• Murphy TF. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis. 2008;47:1534–1536.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411.
   PubMed Web of Science ®Google Scholar
• Riley RD, Moons KGM, Snell KIE, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019;364:k4597.
   PubMed Web of Science ®Google Scholar
• Hayden JA, Côté P, Steenstra IA, Bombardier C, QUIPS-LBP Working Group. Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies. J Clin Epidemiol. 2008;61:552–560.
   PubMed Web of Science ®Google Scholar
• Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280–286.
   PubMed Web of Science ®Google Scholar
• Foroutan F, Guyatt G, Zuk V, et al. GRADE Guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. J Clin Epidemiol. 2020;121:62–70.
   PubMed Web of Science ®Google Scholar
• Choi J, Oh JY, Lee YS, et al. Pseudomonas aeruginosa infection increases the readmission rate of COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3077–3083.
   PubMed Web of Science ®Google Scholar
• Bouquet J, Tabor DE, Silver JS, et al. Microbial burden and viral exacerbations in a longitudinal multicentre COPD cohort. Respir Res. 2020;21(1):77.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M, and Study Group of Bacterial Infection in COPD. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116:40–46.
   PubMed Web of Science ®Google Scholar
• Araújo D, Shteinberg M, Aliberti S, et al. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018;51:1701953.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Miravitlles M, De la Rosa Carrillo D, Cantón R, Soler-Cataluña JJ, Martinez-Garcia MA. Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease. J Clin Med. 2020;9:E1639.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Anzueto A. Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics? Int J Mol Sci. 2017;18:E1344.
   PubMed Web of Science ®Google Scholar
• De la Rosa Carrillo D, Martínez-García MÁ, Barreiro E, et al. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study. Arch Bronconeumol. 2022;58:11–21.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355–2365.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Marín A, Monsó E, et al. Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD. Eur Respir J. 2009;34:1066–1071.
   PubMed Web of Science ®Google Scholar
• Henkle E, Curtis JR, Chen L, et al. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019;54:1801896.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Faner R, Oscullo G, et al. Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis. Am J Respir Crit Care Med. 2020;201:1078–1085.
   PubMed Web of Science ®Google Scholar
• Eklöf J, Ingebrigtsen TS, Sørensen R, et al. Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Thorax. 2021:thoraxjnl-2021-217160. doi:10.1136/thoraxjnl-2021-217160
   PubMed Web of Science ®Google Scholar
• Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions. Eur Respir J. 2018;52:pii: 1800328.
   Web of Science ®Google Scholar
• Padilla-Galo A, Olveira Fuster C. Bronchiectasis in COPD and Asthma. More Than Just a Coincidence. Arch Bronconeumol. 2019;55:181–182.
   PubMed Web of Science ®Google Scholar